PD Dr. med. Maximilian Meyer

Pichler, Eva-Maria, Mosandl, Felix, Kronschnabel, Jens, Meyer, Maximilian, Guessoum, Adrian, Herrmann, Oliver, Curiger, Jacqueline, Vogel, Marc, Walter, Marc, & Baltes-Flückiger, Lavinia. (2026). Recreational cannabis access via pharmacies: A 1-year Swiss study on cannabis use and mental health [Journal-article]. Drug and Alcohol Dependence, 288, 1–10. https://doi.org/10.1016/j.drugalcdep.2026.113337

Mosandl, C. Felix, Pichler, Eva-Maria, Meyer, Maximilian, Guessoum, Adrian, Herrmann, Oliver, Curiger, Jacqueline, Kronschnabel, Jens, Vogel, Marc, Walter, Marc, & Baltes-Flueckiger, Lavinia. (2026). Bidirectional association of psychopathology and cannabis use: Results from the Swiss study on recreational cannabis access via pharmacies. Journal of Affective Disorders, 405. https://doi.org/10.1016/j.jad.2026.121604

Meyer, Maximilian, Mosandl, C. Felix, Guessoum, Adrian, Herrmann, Oliver, Baltes-Flückiger, Lavinia, Pichler, Eva-Maria, Zadic, Amar, Maleska Maceski, Aleksandra, Vilchez Gomez, Juan Francisco, Dürsteler, Kenneth M., Müller, Felix, Lang, Undine E., Benkert, Pascal, Kuhle, Jens, Walter, Marc, & Vogel, Marc. (2026). NfL and GFAP quantification and associations with mental health in recreational cannabis users—Results from the Swiss study on recreational cannabis access via pharmacies. Molecular Neurobiology, 63(1). https://doi.org/10.1007/s12035-026-05798-9

Schwarz, T., Anzenberger, J., Busch, M., Gmel, G., Kraus, L., Krausz, R. M., Labhart, F., Meyer, M., Schaub, M. P., Westenberg, J. N., & Uhl, A. (2025). Corrigendum/Erratum to “Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland” (Drug and Alcohol Dependence (2024) 254, (S0376871623012747), (10.1016/j.drugalcdep.2023.111036)). Drug and Alcohol Dependence, 276. https://doi.org/10.1016/j.drugalcdep.2025.112887

Meyer, Maximilian, Quinto, Adrian, Guessoum, Adrian, Strasser, Johannes, Dürsteler, Kenneth, Lang, Undine, & Vogel, Marc. (2025). Operational and clinical procedures of heroin-assisted treatment in Switzerland: a nation-wide survey study. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01325-6

Baltes-Flueckiger, Lavinia, Steinauer, Regine, Meyer, Maximilian, Guessoum, Adrian, Herrmann, Oliver, Mosandl, Christoph Felix, Kronschnabel, Jens, Pichler, Eva-Maria, Vogel, Marc, & Walter, Marc. (2025). Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial. Addiction, 120, 1982–1992. https://doi.org/10.1111/add.70080

Guessoum, Adrian, Vogt, Severin B., Meyer, Maximilian, Westenberg, Jean Nicolas, Klemperer, Benjamin, Dürsteler, Kenneth M., Liechti, Matthias E., Thomann, Jan, Luethi, Dino, Duthaler, Urs, & Vogel, Marc. (2025). Pharmacokinetics and Pharmacodynamics of Intranasal Diacetylmorphine in Heroin-Assisted Treatment for Severe Opioid Use Disorder. CNS Drugs, 39(8), 807–817. https://doi.org/10.1007/s40263-025-01189-1

Strickler, Elisabeth, Wicki, Zacharias, Westenberg, Jean N., Strasser, Johannes, Lang, Undine E., Dürsteler, Kenneth M., Meyer, Maximilian, & Vogel, Marc. (2025). Diversion of diacetylmorphine in heroin-assisted treatment – a focus group study among patients and treatment providers [Journal-article]. European Addiction Research, 31(2), 87–98. https://doi.org/10.1159/000545162

Meyer, Maximilian, Strazdins, Eriks, Guessoum, Adrian, Westenberg, Jean N., Appenzeller‐Herzog, Christian, Cattaneo, Marco E. G. V., Krausz, R. Michael, Dürsteler, Kenneth M., Lang, Undine E., Hemkens, Lars G., & Vogel, Marc. (2025). Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta-analysis [Journal-article]. Addiction, 120(6), 1112–1126. https://doi.org/10.1111/add.70000

Meyer, Maximilian, Strasser, Johannes, & Brězan, Franciska. (2025). Diversifizierte Medikamentenwahl in der opioidgestützten Behandlung. Suchtmedizin - Addiction Medicine, 1(27), 7–18. https://www.ecomed-suchtmedizin.de/archiv/suchtmedizin-band-27-nr-1-2025

Meyer, Maximilian, Wagner, Aline, Schmidt, André, Schaub, Anna-Chiara, Lang, Undine E., Walter, Marc, & Colledge, Flora. (2025). Stability of exercise addiction symptoms and co-occurring mental disorders – a follow-up study. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1494309

Azar, Pouya, Schneiderman, Hannah, Barron, Henry, Wong, James S. H., Meyer, Maximilian, Newman-Azar, Dayyon, Narimani, Matin, Ignaszewski, Martha J., Mathew, Nickie, Mullen, Rodney, Krausz, Reinhard M., & Maharaj, Anil R. (2024). Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder. Addiction Science and Clinical Practice, 19(1). https://doi.org/10.1186/s13722-024-00479-1

Köck, Patrick, Badek, Andrzej, Meyer, Maximilian, Klaassen, Arndt-Lukas, Walter, Marc, & Kindler, Jochen. (2024). Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials. Child and Adolescent Psychiatry and Mental Health, 18(1). https://doi.org/10.1186/s13034-024-00846-5

Mosar, Francesca, Spitzer, Ursula S., Meyer, Maximilian, Guggisberg, Elisa, Lüthy, Alyssa, Walter, Marc, Vogel, Marc, & Dürsteler, Kenneth M. (2024). Lifestyle changes during first COVID-19 lockdown: A survey in patients on opioid agonist therapy and medical students in Switzerland. Heroin Addiction and Related Clinical Problems, 26. https://doi.org/10.62401/2531-4122-2024-65

Brezan, Franciska, Meyer, Maximilian, Vogel, Marc, Heimer, Jakob, Falcato, Luis, Montagna, Jonas, & Bruggmann, Philip. (2024). Prolonged diacetylmorphine take-home during the COVID-19 pandemic—Results of a retrospective cohort study. Addiction, 119(8), 1421–1429. https://doi.org/10.1111/add.16503

Schaub, Anna-Chiara, Meyer, Maximilian, Tschopp, Amos, Wagner, Aline, Lang, Undine E., Walter, Marc, Colledge, Flora, & Schmidt, André. (2024). Brain alterations in individuals with exercise dependence: A multimodal neuroimaging investigation. Journal of Behavioral Addictions, 13(2), 565–575. https://doi.org/10.1556/2006.2024.00028

Thomann, Jan, Vogt, Severin B., Guessoum, Adrian, Meyer, Maximilian, Vogel, Marc, Liechti, Matthias E., Luethi, Dino, & Duthaler, Urs. (2024). Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1237. https://doi.org/10.1016/j.jchromb.2024.124104

Baltes-Flueckiger, Lavinia, Wagner, Aline, Sattler, Isabel, Meyer, Maximilian, Tschopp, Amos, Walter, Marc, & Colledge, Flora. (2024). How depression and ADHD relate to exercise addiction: a cross-sectional study among frequent exercisers. Frontiers in Psychology, 15. https://doi.org/10.3389/fpsyg.2024.1427514

Krausz RM, Westenberg JN, Tai AMY, Fadakar H, Seethapathy V, Mathew N, Azar P, Phillips A, Schütz CG, Choi F, Vogel M, Cabanis M, Meyer M, Jang K, & Ignaszewski M. (2024). A Call for an Evidence-Based Strategy Against the Overdose Crisis. Canadian Journal of Psychiatry, 69(1), 5–9. https://doi.org/10.1177/07067437231188202

Mayer-Eckardt, Lennart N., Gnirss, Ole, Meyer, Maximilian, Roser, Katharina, Dürsteler, Kenneth M., & Vogel, Marc. (2024). Somatic and mental health among older patients in opioid agonist therapy: a cross-sectional geriatric assessment study. Heroin Addiction and Related Clinical Problems, 26(1). https://doi.org/10.62401/2531-4122-2024-2

Mosandl, Christoph Felix, Baltes-Flückiger, Lavinia, Kronschnabel, Jens, Meyer, Maximilian, Guessoum, Adrian, Herrmann, Oliver, Vogel, Marc, Walter, Marc, & Pichler, Eva-Maria. (2024). Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1356988

Schwarz, Tanja, Anzenberger, Judith, Busch, Martin, Gmel, Gerhard, Kraus, Ludwig, Krausz, Michael, Labhart, Florian, Meyer, Maximilian, Schaub, Michael P., Westenberg, Jean N., & Uhl, Alfred. (2024). Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland [Journal-article]. Drug and Alcohol Dependence, 254, 111036. https://doi.org/10.1016/j.drugalcdep.2023.111036

Zullino, Daniele, Vogel, Marc, Meyer, Maximilian, Simon, Olivier, Bisson, Maëlle, Corino, Tamara, & Penzenstadler, Louise. (2024). Addiction: what’s new in 2023. Revue Medicale Suisse, 20, 12–14. https://doi.org/10.53738/REVMED.2024.20.856-7.12

Mosandl C.F., Baltes-Flückiger L., Kronschnabel J., Guessoum A., Herrmann O., Meyer, M., Vogel, M., Walter, M., & Pichler, E-M. (2023). Depressivität prädiktiv für Cannabiskonsummuster? - Erste Daten der Basler “WeedCare”-Studie zum regulierten Cannabisverkauf zu Genusszwecken. Suchtmedizin - Addiction Medicine, 4(25), 1–7.

Tai A.M.Y., Meyer M., Varidel M., Prodan A., Vogel M., Iorfino F., & Krausz, R.M. (2023). Exploring the potential and limitations of ChatGPT for academic peer-reviewed writing: Addressing linguistic injustice and ethical concerns. Journal of Academic Language & Learning, 1(17), 15. https://journal.aall.org.au/index.php/jall/article/view/903

Meyer, Maximilian, Gygli, Ferdinand, Westenberg, Jean N., Schmid, Otto, Strasser, Johannes, Lang, Undine E., Dürsteler, Kenneth M., & Vogel, Marc. (2023). Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study. Addiction Science and Clinical Practice, 18(1). https://doi.org/10.1186/s13722-023-00397-8

Meyer, Maximilian, Westenberg, Jean N., Jang, Kerry L., Choi, Fiona, Schreiter, Stefanie, Mathew, Nickie, King, Conor, Lang, Undine E., Vogel, Marc, & Krausz, R. Michael. (2023). Shifting drug markets in North America - a global crisis in the making? International Journal of Mental Health Systems, 17(1). https://doi.org/10.1186/s13033-023-00601-x

Vogel M, Meyer M, Westenberg JN, Kormann A, Simon O, Salim Hassan Fadlelseed R, Kurmann M, Bröer R, Devaud N, Sanwald U, Baumgartner S, Binder H, Strasser J, Krausz RM, Beck T, Dürsteler KM, & Falcato L. (2023). Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study. Harm Reduction Journal, 20(1), 2. https://doi.org/10.1186/s12954-023-00731-y

Westenberg JN, Meyer M, Strasser J, Krausz M, Dürsteler KM, Falcato L, & Vogel M. (2023). Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study. Addiction Science and Clinical Practice, 18(1), 15. https://doi.org/10.1186/s13722-023-00367-0

Fadakar, H., Kim, J., Saunders, L. C., Kamel, M. M., Kianpoor, M., Moghadam, A. H., Hayati, D., Ramadhan, N., Maragha, T., Meyer, M., Jang, K., & Krausz, R. M. (2023). Suicidality among university students in the Eastern Mediterranean region: A systematic review [Journal-article]. PLOS Global Public Health, 3(10 October), e0002460. https://doi.org/10.1371/journal.pgph.0002460

Kim JJ, Nikoo M, Nikoo N, Javidanbardan S, Kazemi A, Choi F, Gholami A, Lafooraki NY, Vogel M, Rezazadeh-Azar P, Meyer M, Cabanis M, Jang K, Aknondzadeh S, & Krausz M. (2023). Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial. Drug and Alcohol Dependence, 249, 110874. https://doi.org/10.1016/j.drugalcdep.2023.110874

Tschopp Amos, Meyer Maximilian, Sattler Isabel, Walter Marc, & Colledge Flora. (2023). Exercise Addiction and Major Depressive Disorder – Clinical Diagnoses and Longitudinal Course. Addiction and Health, 15(2), 144–148. https://doi.org/10.34172/ahj.2023.1404

Meyer, M., Appenzeller-Herzog, C., Cattaneo, M., & Hemkens, L. G. (2023, March 7). Adverse effects of opioids prescribed in opioid agonist treatment: a systematic review protocol [Posted-content]. Center for Open Science. https://doi.org/10.31219/osf.io/h2nr6

Mayer-Eckardt, L. N., Gnirss, O., Meyer, M., Roser, K., Dürsteler, K. M., & Vogel, M. (2023). Somatic and Mental Health Among Older Patients in Opioid Agonist Therapy: A Cross-Sectional Geriatric Assessment Study [Posted-content]. Heroin Addiction and Related Clinical Problems. https://doi.org/10.2139/ssrn.4428985

Meyer, Maximilian, Westenberg, Jean N., Brunner, Patrick, Gürtler, Martin, Wiesbeck, Gerhard A., Lang, Undine E., Vogel, Marc, & Dürsteler, Kenneth M. (2023). Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: a cross-sectional study. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1204236

Meyer M., Westenberg J.N., & Krausz R.M. (2023). The Fentanyl System Shock – Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on “The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic”. International Journal of Health Policy and Management, 12(1). https://doi.org/10.34172/ijhpm.2023.7409

R. Michael Krausz, Alireza Kazemi, Fiona Choi, Stefanie Schreiter, Maximilian Meyer, & Maurice Cabanis. (2023). Online-Strategie gegen die Opioid-Überdosiskrise in Kanada – RAMP eine Plattform zum Risikomanagement für Drogenkonsumenten. Suchtmedizin - Addiction Medicine.

Shams, F., Tai, A. M. Y., Kim, J., Boyd, M., Meyer, M., Kazemi, A., & Krausz, R. M. (2023). Adherence to e-health interventions for substance use and the factors influencing it: Systematic Review, meta-analysis, and meta-regression. Digital Health, 9. https://doi.org/10.1177/20552076231203876

Flückiger, L., Meyer, M., & Walter, M. (2022). Studie zum regulierten Cannabisverkauf zu Genusszwecken in Basel. Suchtmedizin - Addiction Medicine, 5(24), 235–242.

Westenberg, J.N., Meyer, M., Röhrig, J., Cabanis, M., Elsner, J., Vogel, M., Dürsteler, K.M., & Krausz, R.M. (2022). Prävention, Behandlung und Management von hochriskantem Substanzkonsum und Überdosen unter Jugendlichen - eine internationale Delphi-Studie. Suchtmedizin - Addiction Medicine, 5(24), 243–248.

Tai, Andy Man Yeung, Suen, Janet, Chopra, Gurpreet, Westenberg, Jean Nicholas, Elsner, Julie, Cabanis, Maurice, Kamel, Mostafa Mamdouh, Schomerus, Georg, Bluhm, Marie, Maremmani, Angelo Giovanni Icro, Moghadam, Arash, Meyer, Maximilian, Choi, Fiona, & Krausz, Reinhard Michael. (2022). Personal and educational experiences of medical students on attitudes towards Psychiatry [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-2299344/v1

Meyer M, Rist B, Strasser J, Lang UE, Vogel M, Dürsteler KM, & Walter M. (2022). Exploring why patients in heroin-assisted treatment are getting incarcerated—a qualitative study. BMC Psychiatry, 22(1), 169. https://doi.org/10.1186/s12888-022-03814-5

Meyer M, Westenberg JN, Strasser J, Dürsteler KM, Lang UE, Krausz M, & Vogel M. (2022). Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment. Harm Reduction Journal, 19(1), 63. https://doi.org/10.1186/s12954-022-00644-2

Krausz RM, Westenberg JN, Meyer M, & Choi F. (2022). The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster (Patent No. 9). The Lancet Psychiatry, 9(9), Article 9. https://doi.org/10.1016/s2215-0366(22)00241-3

Colledge F, & Meyer M. (2022). Exercise Addiction - Status, Identification and Treatment. Praxis, 111(6), 317–321. https://doi.org/10.1024/1661-8157/a003875

Meyer M, Brunner P, Geissmann L, Gürtler M, Schwager F, Waldis R, Vogel M, Wiesbeck GA, & Dürsteler KM. (2022). Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice—Identifying Group Differences and Predictors. Frontiers in Psychiatry, 13, 846834. https://doi.org/10.3389/fpsyt.2022.846834

Meyer M, Strasser J, Köck P, Walter M, Vogel M, & Dürsteler KM. (2022). Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted? International Journal of Drug Policy, 101, 103548. https://doi.org/10.1016/j.drugpo.2021.103548

Köck P, Meyer M, Elsner J, Dürsteler KM, Vogel M, & Walter M. (2022). Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders – A Narrative Review. Frontiers in Psychiatry, 13, 827658. https://doi.org/10.3389/fpsyt.2022.827658

Ursula Spitzer, Maximilian Meyer, Elisa Guggisberg, Klaudia Mirek, Marc Walter, & Kenneth M. Dürsteler. (2022). Results of a survey among opioid addiction treatment providers on the importance of physical exercise. Heroin Addiction an Related Clinical Problems.

Lavinia Flückiger, Maximilian Meyer, Regine Steinauer, & Marc Walter. (2021). Cannabisregulierung - eine internationale Herausforderung [Übersichtsarbeit]. Suchtmedizin - Addiction Medicine, 5(23), 319–326.

Maximilian Meyer, Anna-Katharina Mücke, Johannes Strasser, Marc Walter, & Marc Vogel. (2021). Nasale Applikationsform in der opioidgestützten Behandlung [Übersichtsarbeit]. Suchtmedizin - Addiction Medicine, 4(23), 219–224.

Maximilian Meyer, Lavinia Flückiger, Regine Steinauer, & Marc Walter. (2021). Cannabiskonsum und Cannabisabhängigkeit - ein Update [Übersichtsarbeit]. Suchtmedizin - Addiction Medicine, 5(23), 307–317.

Meyer M, Sattler I, Schilling H, Lang UE, Schmidt A, Colledge F, & Walter M. (2021). Mental Disorders in Individuals With Exercise Addiction—A Cross-Sectional Study. Frontiers in Psychiatry, 12, 751550. https://doi.org/10.3389/fpsyt.2021.751550

Meyer M, Eichenberger R, Strasser J, Dürsteler KM, & Vogel M. (2021). «One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment. Harm Reduction Journal, 18(1), 134. https://doi.org/10.1186/s12954-021-00584-3

Meyer M, Walter M, Borgwardt S, Scheidegger A, Lang E, & Köck P. (2021). Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder [Frontiers Media S.A.]. Frontiers in Psychiatry, 12, 712110. https://doi.org/10.3389/fpsyt.2021.712110

Meyer M., Hachtel,Henning, & Graf M. (2019). Peculiarities of the therapeutic relationship with forensic psychiatric patients Besonderheiten in der therapeutischen Beziehung bei forensisch-psychiatrischen Patienten. Forensische Psychiatrie, Psychologie, Kriminologie, 13(4), 362–370. https://doi.org/10.1007/s11757-019-00559-y